A malignant neoplasm involving the biliary tree
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
The limited documentation surrounding biliary tract cancer can be frustrating. This condition affects fewer individuals than many other cancers, leading to fewer systematic clinical studies and a lack of comprehensive data. Additionally, the complexity of the biliary system and the variability in clinical presentation contribute to the challenges in characterizing this cancer fully.
To navigate your care effectively, consider seeking a specialist in gastrointestinal oncology who has experience with biliary tract cancers. You may also want to explore participation in clinical trials, which could provide access to cutting-edge therapies. For additional resources, you can visit GARD at rarediseases.info.nih.gov for information on rare diseases. While there are currently no specific patient organizations identified for biliary tract cancer, engaging with broader cancer support networks may provide valuable community support.
There are currently 320 active clinical trials investigating various aspects of biliary tract cancer. Notably, there are several orphan drugs designated for this condition, including Envafolimab and Mefuparib Hydrochloride Tablets, among others. For more information on ongoing trials, you can search at ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=biliary%20tract%20cancer.
Actionable guidance for navigating care for biliary tract cancer
To navigate your care effectively, consider seeking a specialist in gastrointestinal oncology who has experience with biliary tract cancers. You may also want to explore participation in clinical trials, which could provide access to cutting-edge therapies. For additional resources, you can visit GARD at rarediseases.info.nih.gov for information on rare diseases. While there are currently no specific patient organizations identified for biliary tract cancer, engaging with broader cancer support networks may provide valuable community support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 16 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.